Literature DB >> 562508

[Induced hypocalcaemia test using salmon calcitonin as a means for the evaluation of osteoclastic activity (author's transl)].

D Blanc, M C Chapuy, P Meunier.   

Abstract

The authors measured the degree of hypocalcaemia (delta Ca S), hypophosphataemia and the fall in urinary hydroxyproline excretion induced by an intramuscular injection of 100 MRC U of synthetic salmon calcitonin (S.C.T.) during the 24 hours following the injection. In 15 control subjects, the fall in plasma calcium was slight ( - 2.1 +/- 0.9 mg/l) but significant. In bone diseases involving hyperosteoclastosis, the degree of hypocalcaemia was much greater: 10.6 +/- 1.1 mg/l in 24 cases of Paget's disease, - 9.0 +/- 1.6 mg/l in 5 cases of diffuse malignant disease of bone, - 8.0 +/- 1.4 mg/l in 6 cases of primary hyperparathyroidism and - 3.5 +/- 0.8 mg/l in 13 cases of algodystrophy of the limbs. In the subjects studied as a whole there was a significant linear relationship between the delta Ca S and the extent of the trabecular surfaces of osteoclastic resorption, but not between delta Ca S and total 24 hour urinary hydroxyproline excretion. The S.C.T. hypocalcaemia test would appear to be a simple means for the evaluation of osteoclastic activity within the skeleton, and thus to select those bone disorders which should respond to antiosteoclastic therapy (calcitonin, diphosphonates).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 562508

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  2 in total

1.  Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women.

Authors:  D González; G Ghiringhelli; C Mautalen
Journal:  Calcif Tissue Int       Date:  1986-02       Impact factor: 4.333

2.  Intranasal calcitonin and plasma calcium concentrations.

Authors:  C Nagant de Deuxchaisnes; J P Devogelaer; J P Huaux; J P Dufour; W Esselinckx
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.